February 2020
Vol 7 | Issue 284

Q&A with Brooks Powell of Cheers®

CEO and Founder

Principle Series:

Ever Been Hungover?

Have you been on “Shark Tank” and have $16 million in online only sales and nearly cash positive in 2 years? No?

Cheers to Cheers® ! They did.

If you missed meeting Brooks at the Family Office Insights private luncheon on February 14th, you can connect with them him as a potential investor: HERE

Also Brooks has kindly offered us 20% off Cheers® products through the end of February .

The discount code on cheershealth.com is “FOI20”. You simply enter it at checkout

FOI does not get paid if you purchase products or invest just to be clear.


Family Office Insights is a voluntary, “opt-in” collaborative peer-to-peer community of single family offices, qualified investors and institutional investors. Join the community here www.familyofficeinsights.com



Brooks Powell of Cheers®

Brooks Powell is a graduate of Princeton University (’17) where he first started Cheers (formerly called Thrive+). Brooks earned the Tiger Entrepreneur Award (the highest award that an alumnus within 5 years of graduating can earn). Brooks completed a certificate program in entrepreneurship (the equivalent of a minor) and participated in Princeton’s Summer eLab Accelerator Program in both 2016 & 2017. While at Princeton, Brooks wrote a 100+ page junior paper (similar to a thesis) on “A Biblical Theology of Man’s Relationship to Matter: Using Alcohol as a Case Study Within the Biblical Narrative” and later gave a TEDxPrincetonU talk on “Taming Alcohol’s Dark Side”—which discussed the intersection of alcohol ethics and his brand of DHM-based products. Two years since graduating, Brooks has built Cheers into a $10m annual revenue business and partnered with Princeton and two equity holding Princeton biotech professors through sponsored research agreements (SRAs) to increase the bioavailability of DHM. Today, Brooks is listed as a co-inventor with various Princeton professors and post-docs on multiple licensable bioavailability patents.